Skip to main content

Protein-supplemented DNA/MVA vaccines: Preclinical immunogenicity and protection for transmitted/founder (B.63521 Delta 11mutC) and CD4-induced gp120 (rhFLSC) proteins

Publication ,  Conference
Robinson, HL; Basu, R; Schwartz, JA; Hauser, MJ; Demarco, CT; DeVico, AL; Haynes, BF; Andersen, H
Published in: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
July 1, 2019

Duke Scholars

Published In

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY

EISSN

1758-2652

Publication Date

July 1, 2019

Volume

22

Start / End Page

19 / 20

Publisher

JOHN WILEY & SONS LTD

Related Subject Headings

  • 4206 Public health
  • 4202 Epidemiology
  • 3202 Clinical sciences
  • 1199 Other Medical and Health Sciences
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Robinson, H. L., Basu, R., Schwartz, J. A., Hauser, M. J., Demarco, C. T., DeVico, A. L., … Andersen, H. (2019). Protein-supplemented DNA/MVA vaccines: Preclinical immunogenicity and protection for transmitted/founder (B.63521 Delta 11mutC) and CD4-induced gp120 (rhFLSC) proteins. In JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (Vol. 22, pp. 19–20). JOHN WILEY & SONS LTD.
Robinson, H. L., R. Basu, J. A. Schwartz, M. J. Hauser, C. T. Demarco, A. L. DeVico, B. F. Haynes, and H. Andersen. “Protein-supplemented DNA/MVA vaccines: Preclinical immunogenicity and protection for transmitted/founder (B.63521 Delta 11mutC) and CD4-induced gp120 (rhFLSC) proteins.” In JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 22:19–20. JOHN WILEY & SONS LTD, 2019.
Robinson HL, Basu R, Schwartz JA, Hauser MJ, Demarco CT, DeVico AL, et al. Protein-supplemented DNA/MVA vaccines: Preclinical immunogenicity and protection for transmitted/founder (B.63521 Delta 11mutC) and CD4-induced gp120 (rhFLSC) proteins. In: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. JOHN WILEY & SONS LTD; 2019. p. 19–20.
Robinson, H. L., et al. “Protein-supplemented DNA/MVA vaccines: Preclinical immunogenicity and protection for transmitted/founder (B.63521 Delta 11mutC) and CD4-induced gp120 (rhFLSC) proteins.” JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, vol. 22, JOHN WILEY & SONS LTD, 2019, pp. 19–20.
Robinson HL, Basu R, Schwartz JA, Hauser MJ, Demarco CT, DeVico AL, Haynes BF, Andersen H. Protein-supplemented DNA/MVA vaccines: Preclinical immunogenicity and protection for transmitted/founder (B.63521 Delta 11mutC) and CD4-induced gp120 (rhFLSC) proteins. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. JOHN WILEY & SONS LTD; 2019. p. 19–20.

Published In

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY

EISSN

1758-2652

Publication Date

July 1, 2019

Volume

22

Start / End Page

19 / 20

Publisher

JOHN WILEY & SONS LTD

Related Subject Headings

  • 4206 Public health
  • 4202 Epidemiology
  • 3202 Clinical sciences
  • 1199 Other Medical and Health Sciences
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences